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Radiosurgery (RS) treatment times vary, even for the same prescription dose, due to variations in the
collimator size, the number of iso-centres/beams/arcs used and the time gap between each of these
exposures. The biologically effective dose (BED) concept, incorporating fast and slow components of
repair, was used to show the likely inﬂuence of these variables for Gamma Knife patients with Vestibular
Schwannomas. Two patients plans were selected, treated with the Model B Gamma Knife, these rep-
resenting the widest range of treatment variables; iso-centre numbers 3 and 13, overall treatment times
25.4 and 129.6 min, prescription dose 14 Gy. These were compared with 3 cases treated with the Per-
fexion® Gamma Knife. The iso-centre number varied between 11 and 18, treatment time 35.7 e 74.4 min,
prescription dose 13 Gy. In the longer Model B Gamma Knife treatment plan the 14 Gy iso-dose was best
matched by the 58 Gy2.47 iso-BED line, although higher and lower BED values were associated with
regions on the prescription iso-dose. The equivalent value for the shorter treatment was 85 Gy2.47. BED
volume histograms showed that a BED of 85 Gy2.47 only covered ~65% of the target in the plan with the
longer overall treatment time. The corresponding BED values for the 3 cases, treated with the Perfexion®
Gamma Knife, were 59.5, 68.5 and 71.5 Gy2.47.
In conclusion BED calculations, taking account of the repair of sublethal damage, may indicate the
importance of reporting overall time to reﬂect the biological effectiveness of the total physical dose
applied.
© 2015 Published by Elsevier Ltd on behalf of Associazione Italiana di Fisica Medica. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In the current clinical practice of radiosurgery (RS), treatment is
usually deﬁned by the total physical dose to an iso-surface which is
conformed as close as is practically possible to the gross tumour
volume (GTV). By way of an example, using the Gamma Knife, a
standard approach is to specify the total physical treatment dose
prescribed to the 50% iso-dose, with no margin. The prescription
dose is thus the maximum dose to normal tissue and the minimum
dose to tumour. In this instance the peak dose to the tumour will be
twice the prescription dose as reﬂected in dose volume histogramsUniversity of Oxford, Oxford,
opewell).
alf of Associazione Italiana di Fisic(DVH). With the introduction of dose optimizing approaches to
maximize the conformity of the prescription iso-dose to the GTV
and to maximize the dose gradient outside the target, the pre-
scription iso-dose can vary [1,2]. Consequently the maximum dose
will differ for a given prescription dose, even though the gradient at
the target periphery may be more consistent between different
treatment plans.
The prescribed total physical dose in a single treatment session
in RS has historically been referred to as a single dose exposure.
However, as pointed out previously, this is not the case for treat-
ments involving multiple iso-centres using the Gamma Knife. The
dose is actually delivered in multiple exposures with varying time
gaps [3,4]. This, to a greater or lesser extent, also applies to other RS
technologies. Using the Gamma Knife the number of iso-centres
used reﬂects the complexity of the plan required to cover the
lesion, although this is subject to practical constraints whena Medica. This is an open access article under the CC BY-NC-ND license (http://
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mated technology, (Perfexion®), the number of iso-centres used
tends to increase for comparable lesions in order to maximise
conformity, which can affect overall treatment times. However, the
time-related decay in the activity of the Cobalt-60 sources will also
have a potentially signiﬁcant effect on overall treatment time for a
given treatment. The overall treatment time should include any
gaps in treatment and not just the radiation beam-on time [3,4]. A
single iso-centre represents the focus of 201 individual collimated
Cobalt-60 sources in the case of the Model B Gamma Knife and 192
sources in the case of Perfexion®, although individual, or groups of
collimators (sectors) may be blocked to reduce the doses to critical
structures.
Currently these variations in the overall treatment time are not
taken into account in treatment planning. However, it is well
known even from early cell survival studies that protraction of a
given dose, by using lower dose-rates, will lead to a loss of bio-
logical effectiveness [5]. Concerns were also expressed following
the introduction of Intensity Modulated Radiotherapy (IMRT) when
conventional 2 Gy fractions were extended beyond the fewminutes
used in conventional radiotherapy. A dose of 2 Gy gradually lost
efﬁcacy, in terms of an increase in clonogenic cell survival, as the
exposure time was gradually increased from a few minutes up to
1 h [6]. Likewise, in terms of normal tissue toxicity, protraction of
the dose has been found to correlate with a decrease in toxicity. For
example, in studies involving the uniform irradiation of a 10 cm
length of spinal cord in pigs, a single dose of 25 Gy delivered in
~30 min resulted in a 100% incidence of radiation myelopathy; that
same dose delivered in ~140min resulted in no cases of myelopathy
(Hopewell, unpublished data).
In addition, within a given patient, there are regional variations
in the constituent doses that are summed, from the different iso-
centres, to produce a given total physical dose. For example for an
individual voxel on a given physical dose iso-surface there will be
variation in the dose-rate due to the collimator used and geometric
orientation for the different iso-centres used. These factors have
implications for the biological effectiveness of the total physical
dose prescribed to that voxel. For some voxels, the majority of the
total dose delivered will come from a single iso-centre, with rela-
tively little contribution from any other iso-centres used in the
treatment. At another anatomical location, on the same total
physical iso-surface, the relative dose contribution from the
different iso-centres may be much more uniform. This variation in
the actual dose protocol delivered to different voxels on the same
total physical iso-surface impacts upon the biological effectiveness
of a given total radiation dose since in the linear quadratic (LQ)
model, biological effectiveness is related to the sum of the dose
from each iso-centre and the dose squared (moderated by the dose-
rate considerations), as illustrated previously in relation to RS [4].
Voxels with the highest dose contribution from a single iso-centre
will have the highest biological effective doses (BED). On a single
physical iso-dose surface, the biological effective dose may vary by
~15% in normal tissue for a given physical dose based treatment
plan [4].
In this paper the role of the concept of biologically effective dose
on treatment planning in RS is explored since at present the wide
variation between different treatment plans does not make it
intrinsically obvious as to the likely biological effectiveness of any
prescription dose. This is particularly so for different Models of
Gamma Knife where the contribution of gaps in exposure to the
overall treatment time vary widely, e.g. with the Model B Gamma
Knife time gaps contribute approximately 50% to the overall
treatment time, while with Perfexion® it is only 2e3%. TwoModel B
treatment plans for Vestibular Schwannomas cases, representing
each end of the spectrum in terms of complexity and treatmentduration, both treated with a physical prescription dose of 14 Gy to
the 50% iso-dose, were chosen. These were compared with three
individual treatments using the Perfexion® Gamma Knife. The
latter patients received a prescription dose of 13 Gy, to slightly
different iso-dose levels, but with overall treatment times that
were in the same range associated with the treatment of the ﬁrst
two patients. Physical treatment plans, and their associated BED
plans, were compared on the basis of iso-dose/iso-BED surfaces on
MRI images and from the comparison of DVH and BED volume
histograms (BEDVH). The objective was to obtain a better under-
standing of the range of BED values and the factors inﬂuencing
them in order to allow the design of an appropriate retrospective
study that would relate BED values to tumour response/normal
tissue complication probability, irrespective of the design of
Gamma Knife or other form of RS that might be used.Materials and methods
Patient population
Two cases were selected from a group of 26 patients treated for
a Vestibular Schwannoma with a Model B Gamma Knife that were
included in an earlier study [4]. Both were treated with a pre-
scription dose of 14 Gy to the 50% physical iso-dose. The protocol
for the ﬁrst patient involved the use of 3 iso-centres, delivered in an
overall treatment time of 25.4 min (2 gaps each of 6 min, 13.4 min
of beam-on time), the second with a total of 13 iso-centres (12 gaps
each 6 min, 57.6 min of beam-on time) in an overall treatment time
of 129.6 min.
The results from the above 2 cases were compared with three
patients treated for Vestibular Schwannomas, with a prescription
iso-dose of 13 Gy using a newer version of Gamma Knife, Perfex-
ion®. These treatments represent the maximum range of overall
treatment times that have been used with these two types of
Gamma Knife at the Cromwell Gamma Knife Centre, London. The
characteristics of these cases are listed in Table 1. The two physical
doses were the most routinely used for patients treated using the
Model B and Perfexion® Gamma Knife, respectively.Calculation of regional variation in biological effective dose
In order to calculate the dose prescription to various points in
the region of interest a prototype research version of Leksell
GammaPlan® has been developed as described previously [4].
Brieﬂy, in this version of Leksell GammaPlan®, the dose-rate asso-
ciated with each iso-centre used could be extracted for each voxel
in a 31  31  31 matrix covering the selected region of interest.
Since the time of exposure for each iso-centre is known the dose
contribution from each iso-centre in each voxel could subsequently
be calculated. It is the summation of the physical dose from each
iso-centre that provides the total physical dose to a speciﬁc voxel.
The BED for each voxel in the 31  31 31 matrix can be calculated
using the following equation:
BED ¼ DT þ
1
a=b

fðX; m1Þ þ cfðX; m2Þ
1þ c
Xn
i¼1
d2i
where fðX;mÞ is a complicated function of the protocol and the
repair rates see ref [7]; the effects of dose-rate, the inter-iso-centre
time and the exposure time are mediated via this function. ‘m1’ and
‘m2’ represent two sublethal radiation damage repair rates that are
associated with protracted exposures and ‘c’ the partition coefﬁ-
cient of the slower component (‘m1’ > ‘m2’). It should be noted that
the absolute partitioning between the two repair processes ‘m1’ and
Table 1
Treatment details for patients with Vestibular Schwannoma receiving a prescription dose of 14 Gy using a Model B Gamma Knife and 13 Gy using a Perfexion® Gamma Knife.
Patient no Gamma knife type Tumour volume (cc) Prescription iso-dose (%) Number of iso-centres Beam on time (min) Overall time (min)a
1 Model B 2.3 50 3 13.4 25.4
2 6.0 50 13 57.6 129.6
1 Perfexion® 4.81 50 13 34.5 35.7
2 1.97 47 11 46.3 47.3
3 2.42 52 18 72.7 74.4
a Average interval of 6.0 or 0.1 min assumed between each iso-centre is included in the overall treatment time for Series B and Perfexion® Gamma Knives, respectively.
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the summation of the different doses delivered to a given voxel by
the treatment, delivered by the ‘n’ iso-centres, where ‘di’ (i ¼ 1,n) is
the dose delivered by each of the ‘n’ different iso-centres. Details of
the derivation of this model and the deﬁnition of fðX;mÞ can be
found elsewhere [7e9]. Experiments in the rat spinal cord, using
single dose exposures delivered at different dose-rates were used
to derive the values of the repair kinetic parameters for normal CNS
tissue that have been used in this analysis [10]. Half-times for the
repair of sublethal irradiation damage of 0.19 h (ln2/m1) and 2.16 h
(ln2/m2); partition coefﬁcient ‘c’ (0.98), were obtained from these
studies with an associated a/b ratio of 2.47 Gy. Comparable a/b
ratios and half-times for repair have been derived from studies
using more conventional fractionated irradiation, with either
complete or incomplete inter-fraction repair intervals, or low and
very low dose-rates have been discussed in detail elsewhere [4,11].
It should be speciﬁcally noted that these repair processes are
deemed to act concurrently resulting in a composite tissue
response. These values have been adopted for use in the present
study to calculate the BED to the normal brain stem; the tumours
treated causing some compression of this normal tissue structure.
Comparable radiobiological parameters are not available for
Vestibular Schwannomas, but in this slowly growing, well differ-
entiated, tumour it would not be unreasonable to suggest that they
may be similar to those for normal CNS tissue.
The 31  31  31 matrix of total physical dose values and BED
values were used to construct relative volume histograms i.e. DVHs
and BEDVHs. For the DVHs the volume was normalized to the
appropriate physical prescription dose, while for the BEDVHs only
the BED values for those voxels that had total physical doses of
14 Gy or 13 Gy were used to construct the BEDVH for Model B
and Perfexion® cases, respectively. The matrix of BED values was
also reimported back into the prototype research version of Leksell
GammaPlan® so that BED iso-lines could be compared with phys-
ical iso-dose lines on the same MR images.Figure 1. Frequency distribution of BED values in a patient treated using 13 iso-
centres, prescription dose 14 Gy (±0.02 Gy) with a Model B Gamma Knife (blue).
The BED values for that iso-dose are compared with those for 13 (red) and 12 Gy
(±0.02 Gy) (green). The comparable most representative BED values for a 3 iso-centre
treatment, prescribed 14 Gy are also plotted for comparison. (For interpretation of the
references to colour in this ﬁgure caption, the reader is referred to the web version of
this article.)Results
Studies of cases treated using the model B gamma knife
The frequency distribution of BED values for voxels irradiated
within the 31  31  31 matrix that received total physical doses of
14, 13 and 12 Gy, are presented in Fig. 1 for the patient treated with
13 iso-centres (129.6 min). The tumour volume was 6.0 cc. In order
to obtain this BED value distribution the physical dose range eval-
uated was widened slightly (±0.02 Gy) to increase the number of
voxels sampled. BED values for each physical dosewere then placed
in bins, e.g. 50.00e50.99 Gy; 51.00e51.99 Gy etc. The peak fre-
quencies of BED values obtained were 45.5, 52.5 and 58.0 Gy2.47, for
total physical iso-doses of 12 (green), 13 (red) and 14 Gy (blue),
respectively. In the subsequent discussion, BED values derived in
this way will be deﬁned as the ‘most representative’ of a given total
physical dose. For simplicity only the corresponding ‘mostrepresentative’ BED values for the 3 iso-centre (25.4min) treatment
are given in Fig. 1. The range of BED values were 60.3e66.21,
68.37e76.49 and 76.74e85.29 Gy2.47 for the total physical doses 12,
13 and 14 Gy, respectively. Although these two patients were pre-
scribed the same total physical dose of 14 Gy to the 50% iso-dose,
the impact of the treatment delivery on the biological effective-
ness of that dose was such that the patient who had the 13 iso-
centre treatment only received a dose equivalent to ~12 Gy, when
compared with the other patient.
The difference between these two treatments is further exem-
pliﬁed by a comparison of their BEDVHs relative to the conventional
DVHs (Fig. 2). The conventional DVHs for the two patients are
similar for total doses between 14 and 18 Gy (relative volume
100e55%), then diverging slightly, converging at the upper dose
limit of 28 Gy. Given that the BED valuemost representative of the 3
iso-centre treatment was 85 Gy2.47 with an upper value of~
270 Gy2.47 representing 28 Gy, for total physical doses of 14 and
28 Gy, the BED axis has been scaled accordingly. Based on this
scaling the BEDVH for the 3 iso-centre patient is reasonably
consistent with the DVH. However, the BEDVH for the 13 iso-centre
patient is markedly shifted to the left. The proportion of the 14 Gy
volume covered by a BED of 85 Gy2.47 in the patient is only ~65%
(see Fig. 2). This difference in coverage can further be illustrated by
the comparison of total dose and BED iso-lines on a treatment plan
image for each of the two treatments (Fig. 3).
Figure 2. Dose volume histograms (solid lines) for the two patients treated with a
model B Gamma Knife illustrated in Figure 1 (prescription dose 14 Gy e maximum
dose 28 Gy). BED volume histograms, for the same two patients, are given for com-
parison (broken lines). A BED value of 85 Gy2.47, that was most representative of the
prescription dose of 14 Gy in the patient treated with 3 iso-centres, only covered ~65%
of the lesion in the patient treated with 13 iso-centres.
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The BED values most representative of the prescription dose of
13 Gy and the lower iso-dose of 12 Gy, in the three Perfexion®
patients evaluated (summarized in Table 1), are given in Table 2,
alongwith the range of BED associatedwith these physical doses. In
these treatments the prescription iso-dose varied above and below
the 50% iso-dose and thus the peak physical dose in the lesions
varied between 25 and 27.8 Gy. The resulting DVHs although, by
deﬁnition, co-incident at the prescription dose of 13 Gy, varied at
higher doses due to differences in the internal dose gradient be-
tween the plans, a function of the iso-centre conﬁguration and
prescription iso-dose selected (Fig. 4). The BEDVHs for the same
three Perfexion® cases are also plotted and compared with theFigure 3. Representative MRI images from the mid plane of the two Vestibular Schwannoma
BED iso-line value of 85 Gy2.47 is broadly co-incident with the prescription iso-dose of 14 Gy
the 14 Gy volume in the patient treated over a longer period with 13 iso-centres. In this patBEDVHs for the two Model B patients. The BEDVH for the Perfex-
ion® case treated with a prescription dose of 13 Gy in the longest
overall treatment time (69.1 min) was very comparable with that
for the model B cases treated in the longest overall treatment time
(14 Gy e 129.6 min). The BEDVH for the Perfexion® case treated
with the shortest overall treatment time was similar to that for the
model B case treated in 25.4 minwith 14 Gy. In all three Perfexion®
cases the85 Gy2.47 BED coverage of the target was less than 100%,
being ~60% in the cases treated in the longest overall treatment
time. For the prescription dose in these cases, at the junction be-
tween normal brain stem and tumour, there is little difference in
the range of BED values between a physical iso-dose of 13 Gy
delivered by Perfexion® and 14 Gy delivered by the Model B
Gamma Knife.Discussion
In RS treatments using the Gamma Knife, the beam-on-time that
is required to deliver a given prescription dose varies widely. Pro-
longation predominantly relates to the complexity of the treatment
plan, largely dependent on an increase in the number of iso-centres
used, on sector/beam blocking, as well as on the activity of the
cobalt-60 sources at the time of treatment. When the time interval
between iso-centres is added to the beam time, to provide the
overall treatment time, then this will be greatly inﬂuenced by the
gap between the individual iso-centres for the older Model B
Gamma Knife. For example, in the present study, set up time was
approximately 47% and 55.5% of the total of 25.4min and 129.6min,
respectively, for the two cases assessed. This assumes an average
interval of 6 min between dose delivery, from each of the iso-
centres. With the introduction of the Perfexion® Gamma Knife
the contribution of gaps to the overall treatment time is signiﬁ-
cantly reduced, being in the order of 2e3% of the overall treatment
time in the 3 cases selected for the present analysis. However, there
was still a wide spread in the overall treatment time for the same
physical prescription dose in these patients. Despite these major
differences in overall treatment time, no account is currently taken
of this in treatment planning in order to adjust for any change in the
biological effectiveness of a given radiation dose. This implies that
there is a belief that there is no repair of sublethal radiation damage
associated with the variations in overall treatment times associated
with RS treatments. Such a conclusion is not consistent with thes treated with a model B Gamma Knife, either with 3 (left) or 13 (right) iso-centres. The
in the 3 iso-centre patient. This iso-BED line encloses a signiﬁcantly small proportion of
ient the 14 Gy prescription iso-dose line is broadly co-incident with a BED of 58 Gy2.47.
Table 2
Variation in BED values associated with the prescription dose (13 Gy) and the 12 Gy
iso-dose for 3 patients with Vestibular Schwannoma using a Perfexion® Gamma
Knife (most representative and the range of values is given).
Patient no. Physical dose (Gy) Representative BED
(range of BED values) (Gy2.47)
1 13 71.5 (65.04e72.17)
12 61.5 (55.96e62.93)
2 13 68.5 (65.26e69.67)
12 59.0 (56.73e59.53)
3 13 59.5 (56.4e61.16)
12 52.5 (49.14e53.26)
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and for in vivo animal studies many of which related to the inﬂu-
ence of dose protraction on the probability of normal tissue com-
plications [10]. Studies using either continuous radiation exposures,
with different dose-rates, or studies involving two or more doses
per day with variable incomplete repair intervals between them
have been used to obtain information related to the kinetics of
repair of sub lethal radiation damage [9], albeit for larger irradiated
volumes. These studies have clearly identiﬁed a fast component of
repair of sublethal radiation injury with a half time of approxi-
mately 0.2 h, which infers that repair of sublethal radiation injury is
an important factor in RS treatments [15]. Moreover, in a previously
unpublished study, that involved the uniform irradiation of a 10 cm
length of the spinal cord of pigs (Hopewell et al., previously un-
published data), a marked difference in response was seen when
doses were delivered at two different dose-rates and therefore
different overall irradiation times. Accounting for planned gaps in
the treatment protocol in this experimental study a total dose of
25 Gy was delivered in approximately 25 min or 140 min, for dose-
rates of 0.9 and 0.2 Gy/min, respectively (for further clariﬁcation
see text to Fig. 5). For this dose the incidence of late radiation
induced myelopathy was reduced from 100% to 0% for the short vsFigure 4. Dose volume histograms (solid lines) for three patients treated in different
overall treatment times with a prescription dose of 13 Gy to between the 47 and 52%
iso-dose using a Perfexion® Gamma Knife. The corresponding BED volume histograms
(broken lines) are plotted for comparison along with the two BED volume histograms
for the two patients treated with a model B Gamma Knife to a higher prescription iso-
dose of 14 Gy (black lines). Despite the difference in prescription dose the biological
effectiveness off all treatments were in the same range.the long overall treatment times, respectively. Below and above
these two doses, delivered using the different dose-rates, the
incidence of myelopathy was clearly dose-related (Fig. 5). The ED50
values (±standard error), the doses associated with a 50% incidence
of radiation myelopathy could be calculated from these dose-effect
curves; they were highly signiﬁcantly different. Based on the
experimentally derived ED50 value of 21.13 Gy for the short treat-
ment, an equivalent value of 26.78 Gy was retrospectively calcu-
lated for the long treatment, assuming the same repair parameters
used in the present study of Gamma Knife patients. This calculated
value of was in good agreement with the experimentally observed
value of 27.02 Gy. A physical prescription dose of 25 Gy is frequently
used for the treatment of arterial venousmalformations (AVM's) for
which overall treatment times, including gaps, can be in excess of
the range associated with the pig study i.e. 20e230 min (P Black-
burn, personal communication, 2012) and so this comparison in the
pig spinal cord, where gaps between beams similar to those asso-
ciated with the Model B Gamma Knife, has considerable relevance
to the current practice of RS. Even an overall treatment time of
230 min still only represents less than 2 half-times for the repair of
sublethal damage via the slow component of 2.16 h (129.6 min) and
thus for all RS treatments the fast component of repair, with a half
time for repair of approximately 12 min, is the dominant factor that
would be responsible for a loss of efﬁcacy with progressive esca-
lation of the treatment time. A modiﬁcation of the basic BED
equation, to just incorporate a single fast component of repair, was
proposed by Joiner et al. [5], in relation to dose protraction in IMRT,
when deﬁning the relationship for small (short treatment times) vs
large fractions (longer treatment times), for a number of normal
tissues represented by biphasic repair kinetics. This methodology
would ignore the potentially signiﬁcant contribution to the BED of
the slow repair process i.e. slow repair would not be taken into
account and would potentially lead to an incorrect value estimate
for the BED.
All of the parameters, use in the present analysis, were experi-
mentally derived from a sufﬁciently powered study involving onlyFigure 5. Dose-related changes in the incidence of radiation induced myelopathy in
the pig, developing 7e16 weeks after irradiation, as a result of selective necrosis of
spinal cord white matter tracks. Irradiation was given at a dose-rate in the spinal cord
of either 0.9 Gy/min [16] or later at a dose-rate of 0.2 Gy/min. In addition to the ~5 min
gaps between opposed ﬁelds, in the case of the longer exposures, at the lower dose-
rate, irradiation was stopped for ~5 min for the treatment to each side to check ﬁeld
positions. The ED50 (±SE), for myelopathy, was calculated from the dose incidence data
for each study. For the lower dose-rate study the ED50 was also calculated using the
repair parameters for the comparison of RS cases.
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at a wide range of differing dose rates [10]. Like all experimentally
derived parameter they were associated with a level of uncertainty.
For example the 95% conﬁdence interval associated with the a/b
ratio of 2.47 Gy was 1.50e3.95 Gy. The use of a different a/b, within
this range, would change the absolute value of the BED values
obtained but would not inﬂuence the ranking of patients. The ef-
fects of changes in the repair parameters has been discussed on
theoretic grounds in a previous study [3], where the value of the
partition coefﬁcient between the fast and slow component of repair
had the greatest inﬂuence on the BED value. The effect of changing
the size of gaps, between iso-centres, was also considered in rela-
tion to the Model B Gamma Knife [3]. BED values declined as the
size of the gap increased, i.e. when overall treatment time, was
increased. Gaps with Perfexion® are very small, ~0.1 min, and
constitutes only a small percentage to the overall treatment time. In
radiobiological terms they can be considered to be continuous ex-
posures, albeit, that at a given location within the treatment vol-
ume the dose-rate varies over the treatment exposure.
In a RS study related to the treatment of trigeminal neuralgia,
typically delivered by a single continuous exposure, a BED model
with a single half-time was used to compare the biological effec-
tiveness of the treatment with protraction of the dose as the ac-
tivity of the Cobalt-60 sources declined [12]. One of a number of
failings of this study, as discussed previously [3], was that dose-rate
was not expressed at the 100% iso-dose in individual patients but as
the machine calibration factor, known as the reference dose-rate,
which decreases with the decay of the Cobalt-60 sources. This
dose-rate does not reﬂect the actual dose-rate in the tissues of in-
dividual patients and as such has should not be used to infer any
differences in biological signiﬁcance. The other error was the se-
lection of a single long half-time for repair of 6.5 h for the BED
calculations. The origins of this selection was not indicated in the
original publication but it would appear that the value came from a
study by Landuyt et al. [13] where a long half-time for repair of
6.4 h was found but in association with a short half-time of 0.25 h.
Repair was deﬁned by a composite bi-exponential function and
thus half-times cannot be selected as an either/or in isolation but
must be used together, a factor that cannot be emphasized enough.
In addition, the simple BED model [14] with no repair components
added, should not be used in relation to RS treatments as that
model only applies to acute exposures that are short compared
with the short component of repair and the time between iso-
centres (or the inter-fraction time) is much greater than the
longer repair half-time. Such short exposures, relative to the fast
half-time for repair, are not relevant to single session or multi-
session RS. It should be pointed out that the generalised bi-phasic
model effectively reduces to the simple standard LQ model when
appropriate conditions, such as those discussed above, are appli-
cable to the irradiation protocol [7,14]. Further the a/b ratio also has
the same value for both formulations; however, it is important that
the most appropriate formula is used in any analysis.
The Model B treatment plans, used in the present analysis,
represented the maximum range of variation in the protocol. This
was both in terms of the least number of iso-centres in the shortest
overall treatment time and the most iso-centres used in the
longest overall treatment time at the Cromwell Hospital Gamma
Knife Centre, London, in the period 1999 to 2005, for a physical
prescription dose of 14 Gy. Thus the BED values of 85 and 58 Gy2.47
represent the maximum variation in biological effective dose in
patients treated with this method and prescription dose [3]. Since
these BED values also represent the highest BED to the normal
brain stem, albeit to a small volume, it is interesting to compare
these values with the BED values commonly delivered to this re-
gion using conventional fractionated radiotherapy. Theconventionally quoted tolerance dose of the brain stem and spinal
cord is a total dose of 50 Gy given as 25 daily (5 times week)
fractions of 2 Gy. Using the same parameters as adopted for the
present analysis this is equivalent to a BED of 90.5 Gy2.47. A more
conservative approach in some radiotherapy centres would be to
limit the brain stem dose to 44 Gy (22 fractions of 2 Gy) for which
the BED is 79.5 Gy2.47. The BED of 85 Gy2.47, obtained for the patient
treated in 25.4 min with three iso-centres is clearly in the range
usually accepted as representing brain stem tolerance to conven-
tional radiotherapy. A total dose of 30 Gy (10 fractions of 3 Gy) is
also conventionally accepted as representing whole brain toler-
ance. This treatment is associated with a BED of 66.4 Gy2.47 and
thus the second patient treated with a prescription dose of 14 Gy in
129.6 min (13 iso-centres) received a lower maximum BED to the
brain stem than would normally be accepted for the whole brain,
even if so called ‘hot spots’ on the prescription in this patients did
exceed a BED of ~65 Gy2.47.
In the present study, the hypothetical maximum BED values
would be 93.4 and 81.4 Gy2.47 for 14 and 13 Gy, respectively. Such
values are calculated using the basic BED equation [4], which as-
sumes that doses are delivered in a short time relative to the fast
half-time for repair and thus that repair of sublethal radiation
damage is not a factor in treatments. Such an assumption is clearly
inappropriate for either single or multi-session RS treatments [15].
Thus the basic BED equation should not be used for estimating the
equivalent dose when converting from experience gained from
treatment with single treatment sessions into multiple treatment
sessions using BED equivalence.
Based on the not unreasonable assumption for these slowly
growing tumours that the repair parameters are similar to those
for the normal central nervous system then the tumour in the
patient receiving the more complex treatment in 129.6 min
received a lower spectrum of biologically effective doses than the
patient receiving the simpler 3 iso-centre treatment. Using a BED
value of 85 Gy2.47 as a reference then only ~60% of the tumour
volume in the more complex plan received this higher biologically
effective dose.
The treatment plans for the three patients treated with the
Perfexion® Gamma Knife, received a prescription dose of 13 Gy.
These are representative of typical treatments delivered at the
Cromwell Hospital Gamma Knife Centre, from 2009 to 2013.
Despite the use of a lower prescription dose of 13 Gy the range of
maximum BED values to the normal brain stem were still in the
range found for the two patients treatment with the Model B
Gamma Knife where the prescription dose was 7.7% higher (14 Gy).
However, it should not be assumed that total physical doses
delivered using the Perfexion® Gamma Knife will be consistently
biologically higher than those delivered using the Model B Gamma
Knife. For example, because of the difference in the relationship
between beam on and off times, in association with the overall
treatment times, a similar overlap in the range of BED values was
also seen in a larger group of patients treated with the Model B
Gamma Knife [9]. BED values of between 60 and 70 were most
representative of a prescription dose of both 13 Gy, when the
overall treatment time varied between 54.55 min (3 iso-centres)
and 124.25 min (8 iso-centres), and 12 Gy, when the overall
treatment time varied between 29.5 min (2 iso-centres) and
50.47 min (5 iso-centres). This would imply that when overall
treatment times vary, as they routinely do in RS, then the concept of
treatment planning using physical radiation dose does not neces-
sarily reﬂect the biological effectiveness of the treatments received,
both between patients and even within the same patient along the
same iso-dose line.
The current prototype research version of GammaPlan does not
allow treatment plans to be conformed to the target using a
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retrospectively calculated for individual voxels. It has been clearly
demonstrated that the BED value is a function of the overall
treatment time, and the dose/dose-rate protocol, including the
number of iso-centres and gaps in the treatment delivery.
Although the hypothetical maximum BED value is related to the
total physical dose, this is based on the assumption that the total
dose is delivered in a short time relative to the fast half-time for
repair. Actual plans with differing physical prescription doses were
associated with the same BED because of the other variables
associated with the different treatment plans. Naturally it would
be of interest to generate BED iso-lines to support treatment
planning. This requires information about the dose-rate history in
every voxel in the calculation matrix to be extracted from Gam-
maPlan©, as well as the radiobiological parameters (repair times
and a/b values of tumours and organs at risk) characterizing the
relevant BED model. The value of these parameters is well estab-
lished for CNS tissue and may be equally applicable to some, if not
all, brain tumours. Planning according to iso-BED would be similar
to planning to a total prescription physical iso-dose with the
exception that BED planning would be done with absolute pre-
scription BED values and thus the total physical dose delivery
would vary according to the complexity of the plan to adequately
cover the target and the time related decay in the activity of the
cobalt-60 sources. High conformity to the iso-BED line would then
be an objective as well as a steep fall off of BED to spare the normal
tissues and organs at risk. Manual BED planning would be feasible
for experienced planners but the creation of an optimization tool
would ease the creation of complex plans with several conﬂicting
objectives and could be a helpful tool for beginners in treatment
planning.
Conclusion
Signiﬁcant variations in overall treatment time have a sub-
stantial effect on the likely biological effectiveness of a given pre-
scription dose in RS. The biological effectiveness of a given physical
prescription dose will decline as the overall treatment time in-
creases, as loss of effectiveness is related to the repair of sublethal
radiation-induced damage over more extended periods of expo-
sure. These ﬁndings provide important additional informationwith
respect to how the biologically effective dose (BED) varies with the
considerable variation in the treatment parameters between
different patients. They strongly support the view that overall
treatment time is perhaps the most important of the different
variables associatedwith BED treatment planning. This information
will help in the design of a comprehensive retrospective studies to
compare BED with effect and/or complication probability in
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